Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Spire Global
SPIR
$552M
| $196K | ﹤0.01% |
24,254
-11,071
| -31% | -$147K |
|
3952
Dakota Gold
DC
$825M
| $196K | ﹤0.01% |
73,852
-34,857
| -32% | -$95.6K |
|
|
TRUE
3953
DELISTED
TrueCar
TRUE
| $195K | ﹤0.01% |
123,687
-22,865
| -16% | -$63.4K |
|
3954
Enanta Pharmaceuticals
ENTA
$398M
| $195K | ﹤0.01% |
35,385
-10,123
| -22% | -$62.5K |
|
3955
Ituran Location and Control
ITRN
$1.06B
| $195K | ﹤0.01% |
5,393
+1,163
| +27% | +$41.9K |
|
3956
OneWater Marine
ONEW
$206M
| $195K | ﹤0.01% |
12,037
-5,934
| -33% | -$102K |
|
|
BRT
3957
BRT Apartments
BRT
$268M
| $195K | ﹤0.01% |
11,455
-5,498
| -32% | -$97K |
|
3958
FT Vest US Equity Enhance & Moderate Buffer ETF August
XAUG
$23.6M
| $194K | ﹤0.01% |
5,695
-180
| -3% | -$6.19K |
|
3959
Cardiff Oncology
CRDF
$79.4M
| $194K | ﹤0.01% |
61,757
-839
| -1% | -$3.32K |
|
3960
NACCO Industries
NC
$320M
| $194K | ﹤0.01% |
5,749
-2,022
| -26% | -$65.2K |
|
3961
ThredUp
TDUP
$414M
| $192K | ﹤0.01% |
79,824
-39,501
| -33% | -$90.9K |
|
3962
OppFi
OPFI
$617M
| $192K | ﹤0.01% |
20,617
-23,904
| -54% | -$266K |
|
3963
OptimizeRx
OPRX
$143M
| $191K | ﹤0.01% |
22,089
-8,485
| -28% | -$51.9K |
|
3964
Advantage Solutions
ADV
$414M
| $191K | ﹤0.01% |
5,064
-2,254
| -31% | -$131K |
|
|
INV
3965
Innventure Inc
INV
$311M
| $190K | ﹤0.01% |
24,658
-3,429
| -12% | -$35.2K |
|
|
GRDN
3966
Guardian Pharmacy Services
GRDN
$2.49B
| $190K | ﹤0.01% |
8,934
-4,275
| -32% | -$87.7K |
|
3967
iShares S&P 100 ETF
OEF
$20.6B
| $190K | ﹤0.01% |
700
| – | – |
|
3968
Cartesian Therapeutics
RNAC
$265M
| $189K | ﹤0.01% |
14,369
-4,730
| -25% | -$84.5K |
|
3969
Getty Images
GETY
$134M
| $189K | ﹤0.01% |
109,012
-49,914
| -31% | -$119K |
|
3970
Motley Fool 100 Index ETF
TMFC
$2.13B
| $188K | ﹤0.01% |
3,387
| – | – |
|
3971
Senseonics Holdings Inc
SENS
$424M
| $188K | ﹤0.01% |
14,351
+14,350
| +1,435,000% | +$237K |
|
3972
Kornit Digital
KRNT
$864M
| $188K | ﹤0.01% |
9,849
-247
| -2% | -$6.46K |
|
|
SEVN
3973
Seven Hills Realty Trust
SEVN
$176M
| $188K | ﹤0.01% |
15,039
-4,195
| -22% | -$54.1K |
|
3974
Utah Medical Products
UTMD
$228M
| $188K | ﹤0.01% |
3,347
-1,936
| -37% | -$116K |
|
|
FHDG
3975
FT Vest U.S. Equity Quarterly Dynamic Buffer ETF
FHDG
$70.5M
| $188K | ﹤0.01% |
6,231
+1,422
| +30% | +$43.8K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.